Search results

82 results for template

Sorted by Relevance . Sort by Date

  1. Safe prescribing of high-risk drugs

    high-risk drugs is implemented via individually designed templates for such drugs. These templates are short, concise and...

  2. Tuberculosis (NG33)

    This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services should be organised, including the role of the TB control board.

  3. Student Champions

    their facilitation skills upon completion of a short reflective report template, receive a certificate of participation signed by the...

  4. Information for Students

    questionnaire). The template for this will be provided. write a short report outlining your experiences as a student champion. A report...

  5. Medicines optimisation in chronic pain (KTT21)

    This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  6. Express scientific advice

    is the key document that the project is centred around. A briefing book template for pharmaceutical companies is available for you to...

  7. NICE-MHRA scientific advice

    is the key document that the project is centred around. A briefing book template for pharmaceutical companies is available for you to...

  8. Standard scientific advice

    requirements for the briefing book submission. Download the briefing book template for: pharmaceutical companies medtech companies Read...

  9. Prostate cancer: diagnosis and management (NG131)

    This guideline covers the diagnosis and management of prostate cancer in secondary care, including information on the best way to diagnose and identify different stages of the disease, and how to manage adverse effects of treatment. It also includes recommendations on follow-up in primary care for people diagnosed with prostate cancer.

  10. Involving you

    to discuss in the meeting. Personal statements are produced using a template which we will email to you (statements are published on...

  11. A Medicines Optimisation Service

    the service, helping them to recruit appropriate staff and developing a template for the clinical system EMIS Web to record the...

  12. The New Faecal Calprotectin Care Pathway

    implementation pack for CCGs and GPs including: Template business cases for CCGs and Trusts Downloadable pathway templates...

  13. Biosimilar medicines (KTT15)

    The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .